Baird initiated coverage of Universal Health with a Neutral rating and $198 price target. The firm started coverage on three Hospital companies with two having Outperform ratings and one with a Neutral rating. Baird believes Hospitals remain well positioned in 2024 to outperform expectations, but long term it remains cautious on the potential secular headwind that could be driven by Value Based Care, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Rubrik and Marex Group initiated: Wall Street’s top analyst calls
- Universal Health upgraded to Buy from Neutral at UBS
- UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND
- Universal Health price target raised to $189 from $183 at RBC Capital
- Universal Health price target raised to $183 from $181 at TD Cowen